YL

Investor profile

Yi Li

Corporate VC & Sr. Director-Medical-Accelerated R&D Leadership Program at Eli Lilly and Company

Yi Li works as a Sr. Director-Medical-Accelerated R&D Leadership Program at Eli Lilly and Company. The firm's known portfolio counts 19 companies.

Is Yi Li a fit for your startup?

Paste your website. AI checks the fit and scores every other investor too.

Investment focus

Contacts

li***@***.comPhone number on fileLinkedIn profile on fileAvailable after registration.
Get contact

Affiliated funds' portfolios

Sr. Director-Medical-Accelerated R&D Leadership Program at Eli Lilly and Company, whose known portfolio counts 19 companies

  • Haya Therapeutics
  • Arda Therapeutics
  • Strand Therapeutics
  • TRex Bio
  • Aktis Oncology
  • Elektrofi
  • Zephyr AI
  • Ajax Therapeutics
  • Artax Biopharma
  • Circle Pharma
  • Sunbird Bio
  • Amprion
  • and 7 more

Investor Profile

Yi Li is listed against sectors AI and Healthcare, and focus areas Biotech, Drug Discovery, Genomics and Machine Learning in the database.

Stage-wise, the deals at Eli Lilly and Company cluster around Growth, Late-Stage and Seed rounds.

What the affiliated firm has backed is the closest available signal on whether Yi Li is worth approaching.

Colleagues at Eli Lilly and Company

Showing 20 of 23

Frequently asked questions

Who is Yi Li?

Yi Li is a corporate venture investor based in Toronto, Ontario, Canada, listed as Sr. Director-Medical-Accelerated R&D Leadership Program at Eli Lilly and Company. The known portfolio of that firm counts 19 companies. That portfolio belongs to the firm, not to Yi Li personally.

What does Yi Li invest in?

Listed sectors include AI and Healthcare; listed focus areas include Biotech, Drug Discovery, Genomics and Machine Learning. Those tags come from the portfolios of the firms this profile is attached to, so they read as a record of what has been backed rather than a stated preference for what comes next.

What stage does Yi Li invest at?

Eli Lilly and Company appears in Growth, Late-Stage and Seed rounds across its known deals, and Yi Li is listed there as Sr. Director-Medical-Accelerated R&D Leadership Program. Stage is the strongest single filter when you build a target list: an investor with no record at your stage rarely starts with you.

Which firm is Yi Li listed at?

Yi Li is listed as Sr. Director-Medical-Accelerated R&D Leadership Program at Eli Lilly and Company. 23 other people in the database share a firm with Yi Li.

How do I contact Yi Li?

An email address, a phone number and a LinkedIn page are on file for Yi Li. The address stays masked on this page and is readable inside RaiseHunt after you create an account.

Skip the browsing. Let AI find your ideal investors in one minute.

Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.

Data: RaiseHunt investor dataset · Snapshot 5 September 2026 · How this data is built · Report a correction or request removal